Annual Drug Patent Expirations for GILOTRIF Gilotrif is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Boehringer Ingelheim drug GILOTRIF appeared f…
New patent for Boehringer Ingelheim drug GILOTRIF Read Post »
Annual Drug Patent Expirations for JORNAY+PM Jornay Pm is a drug marketed by Ironshore Pharms and is included in one NDA. There are thirteen patents protecting this drug. JORNAY PM…
The post New patent for Ironshore Pharms drug JORNAY PM appeared first…
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…
The post Drugs facing the most…
Drugs facing the most patent expirations this year Read Post »
DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The positive responses received made it apparent that the course…
The post Free Online Course on Drug P…
Free Online Course on Drug Patents, Generic and Branded Drugs Read Post »
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWat…
Annual Drug Patent Expirations for SYNDROS Syndros is a drug marketed by Benuvia and is included in one NDA. There are three patents protecting this drug and two Paragraph IV…
The post New patent for Benuvia drug SYNDROS appeared first on DrugPatentWat…
This chart shows the pharmaceutical companies with the most solution dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most solution dosed drugs…
The post Which pharmaceutical companies have the most so…
Which pharmaceutical companies have the most solution dosed drugs? Read Post »
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There are six patents protecting this drug. Drug patent litigation for…
The post New patent for Baudax drug ANJESO appeared first on DrugPatentWat…
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatent…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Luxembourg. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceuti…
Which pharmaceutical companies have the most SPCs in Luxembourg? Read Post »
Get new actionable insights and updates from BiotechBlog
